1
|
Barnes L, Eveson JW, Reichart P and
Sidransky D: Pathology and genetics of head and neck tumours. WHO
Classif Tumour. 9:2912005.
|
2
|
Neville BW, Damm DD, Allen CM and Bouquot
JE: Oral and Maxillofacial Pathology. 3rd (eds). Saunders/Elsevier.
St. Louis, MO: 683–687. 2009.
|
3
|
Mendes RA, Carvalho JFC and van der Waal
I: Characterization and management of the keratocystic odontogenic
tumor in relation to its histopathological and biological features.
Oral Oncol. 46:219–225. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Suemitsu M: A pathomorphological study of
fractal analysis in parenchymal-stromal border on keratocystic
odontogenic tumor-with special reference to proliferative activity
and vascular distribution. Int J Oral-Medical Sci. 10:372–383.
2012. View Article : Google Scholar
|
5
|
Okamoto E, Kikuchi K, Miyazaki Y,
González-Alva P, Oku Y, Tanaka A, Yoshida N, Fujinami M, Ide F,
Sakashita H and Kusama K: Significance of podoplanin expression in
keratocystic odontogenic tumor. J Oral Pathol Med. 39:110–114.
2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Myoung H, Hong SP, Hong SD, Lee JI, Lim
CY, Choung PH, Lee JH, Choi JY, Seo BM and Kim MJ: Odontogenic
keratocyst: Review of 256 cases for recurrence and
clinicopathologic parameters. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 91:328–333. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Selvi F, Tekkesin MS, Cakarer S, Isler SC
and Keskin C: Keratocystic odontogenic tumors: Predictive factors
of recurrence by Ki67 and AgNOR labelling. Int J Med Sci.
9:262–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kuroyanagi N, Sakuma H, Miyabe S, Machida
J, Kaetsu A, Yokoi M, Maeda H, Warnakulasuriya S, Nagao T and
Shimozato K: Prognostic factors for keratocystic odontogenic tumor
(odontogenic keratocyst): Analysis of clinico-pathologic and
immunohistochemical findings in cysts treated by enucleation. J
Oral Pathol Med. 38:386–392. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Jamshidi S, Zargaran M, Baghaei F, Shojaei
S, Zare Mahmoodabadi R, Dehghan A and Moghimbeigi A: An
immunohistochemical survey to evaluate the expression of CD105 and
CD34 in ameloblastoma and odontogenic keratocyst. J Dent (Shiraz).
15:192–198. 2014.PubMed/NCBI
|
10
|
Naruse T, Kawasaki G, Yanamoto S, Mizuno A
and Umeda M: Immunohistochemical study of VEGF expression in oral
squamous cell carcinomas: Correlation with the mTOR-HIF-1α pathway.
Anticancer Res. 31:4429–4437. 2011.PubMed/NCBI
|
11
|
Yuan P, Temam S, El-Naggar A, Zhou X, Liu
DD, Lee JJ and Mao L: Overexpression of podoplanin in oral cancer
and its association with poor clinical outcome. Cancer.
107:563–569. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Friedrich RE, Scheuer HA and Zustin J:
Expression of podoplanin in nevoid basal cell carcinoma
syndrome-associated keratocystic odontogenic tumours. Anticancer
Res. 32:2125–2128. 2012.PubMed/NCBI
|
13
|
Tsuneki M, Maruyama S, Yamazaki M, Cheng J
and Saku T: Podoplanin expression profiles characteristic of
odontogenic tumor-specific tissue architectures. Pathol Res Pract.
208:140–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Evans DG and Farndon PA: Nevoid basal cell
carcinoma syndrome. GeneReviews®. Pagon RA, Adam MP,
Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N,
Mefford HC, Smith RJH and Stephens K: University of Washington.
(Seattle, USA). 2015.
|
15
|
Agaram NP, Collins BM, Barnes L, Lomago D,
Aldeeb D, Swalsky P, Finkelstein S and Hunt JL: Molecular analysis
to demonstrate that odontogenic keratocysts are neoplastic. Arch
Pathol Lab Med. 128:313–317. 2004.PubMed/NCBI
|
16
|
Soluk Tekkeşın M, Mutlu S and Olgaç V:
Expressions of bax, bcl-2 and ki-67 in odontogenic keratocysts
(keratocystic odontogenic tumor) in comparison with ameloblastomas
and radicular cysts. Turk Patoloji Derg. 28:49–55. 2012.PubMed/NCBI
|
17
|
Yanamoto S, Kawasaki G, Yoshitomi I and
Mizuno A: Expression of p53R2, newly p53 target in oral normal
epithelium, epithelial dysplasia and squamous cell carcinoma.
Cancer Lett. 190:233–243. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Toi M, Matsumoto T and Bando H: Vascular
endothelial growth factor: Its prognostic, predictive, and
therapeutic implications. Lancet Oncol. 2:667–673. 2001. View Article : Google Scholar : PubMed/NCBI
|
19
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Alaeddini M, Mostafaloo E,
Mirmohammadkhani O, Eshghyar N and Etemad-Moghadam S: Exploring the
concept of ‘inflammatory angiogenesis’ in keratocystic odontogenic
tumor. Med Oral Patol Oral Cir Bucal. 18:e241–e245. 2013.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhang X, Wang J, Ding X, Xing S, Zhang W
and Wang L, Wu H and Wang L: Altered expression of podoplanin in
keratocystic odontogenic tumours following decompression. Oncol
Lett. 7:627–630. 2014.PubMed/NCBI
|
22
|
González-Alva P, Tanaka A, Oku Y,
Yoshizawa D, Itoh S, Sakashita H, Ide F, Tajima Y and Kusama K:
Keratocystic odontogenic tumor: A retrospective study of 183 cases.
J Oral Sci. 50:205–212. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Chirapathomsakul D, Sastravaha P and
Jansisyanont P: A review of odontogenic keratocysts and the
behavior of recurrences. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 101:5–10. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Morgan TA, Burton CC and Qian F: A
retrospective review of treatment of the odontogenic keratocyst. J
Oral Maxillofac Surg. 63:635–639. 2005. View Article : Google Scholar : PubMed/NCBI
|